In the 5xFAD mouse model of familial AD, the drug was shown to improve long-term memory and promote the spawning of spines while reducing amyloid beta accumulation and tau-related CDK5 kinase phosphorylation, which are important hallmarks of AD [51] (Table 2). Here, MAPT is linked to Alzheimer disease.